Human Immunoglobulin G

CHEBI:CHEBI_751687

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

rxcui
2123042
package_marketing_start_date
20090120
active_ingredient_strength
20 g/200mL
active_ingredient_name
HUMAN IMMUNOGLOBULIN G
pharm_class_moa
Antigen Neutralization [MoA]
pharm_class
Passively Acquired Immunity [PE]
pharm_class_epc
Human Immunoglobulin G [EPC]
pharm_class_cs
Immunoglobulins [CS]
pharm_class_pe
Passively Acquired Immunity [PE]
nui
N0000184008
manufacturer_name
ADMA Biologics, Inc.
unii
66Y330CJHS
spl_set_id
d74f4360-3b51-496c-96fb-84c3976958d2
upc
0369800025027
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
product_type
PLASMA DERIVATIVE
listing_expiration_date
20241231
marketing_start_date
20090120
dosage_form
LIQUID
route
INTRAVENOUS
marketing_category
BLA
generic_name
Human immunoglobulin G
labeler_name
GC Biopharma Corp.
brand_name
Alyglo
brand_name_base
Alyglo
product_ndc
61476-104
application_number
BLA125743
spl_id
692b3911-b195-4499-9790-37e0812b3cde
package_ndc
61476-104-20
package_description
1 VIAL, GLASS in 1 CARTON (61476-104-20) / 200 mL in 1 VIAL, GLASS (61476-104-03)